SRL
PRME icon

Scientech Research LLC’s Prime Medicine PRME Stock Holding History

Scientech Research LLC’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,931
Closed -$62.4K – 474
2026
Q1 		$62.4K Sell
17,931
-4,462
-20% -$17K 0.05% 392
2025
Q4 		$77.7K Buy
+22,393
New +$99.6K 0.05% 421

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Scientech Research LLC's PRME Position: Q2 2026 in Review

Scientech Research LLC sold out of Prime Medicine (PRME) in Q2 2026, closing a stake of 17,931 shares — an estimated $62.4K sold.

Scientech Research LLC first reported a position in PRME in Q4 2025 and held it in 2 quarters. The position peaked at $77.7K in Q4 2025. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Scientech Research LLC reported no remaining Prime Medicine position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 17,931 Prime Medicine shares in Q2 2026, an estimated $62.4K.
  • Scientech Research LLC first reported a position in Prime Medicine in Q4 2025 and held it in 2 quarters.
  • Scientech Research LLC's Prime Medicine position peaked at $77.7K in Q4 2025.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.